Combining a Cannabinoid with MDMA Reverses Memory Impairment in Rats Through a Specific Brain Mechanism
In rats, MDMA (ecstasy) reversed the memory impairment caused by a synthetic cannabinoid through a mechanism involving NMDA glutamate receptors in the hippocampus.
Quick Facts
What This Study Found
Both cannabinoids and MDMA (ecstasy) can impair memory individually, but this study found something unexpected: when given together, MDMA actually reversed the memory problems caused by a synthetic cannabinoid.
The researchers injected the synthetic cannabinoid ACPA directly into the hippocampus of rats, which impaired their ability to remember a passive avoidance task. When MDMA was also injected into the same brain region, it rescued this memory deficit at higher doses.
This reversal effect depended on NMDA receptors, which are critical for memory formation. Blocking NMDA receptors with the drug D-AP5 prevented MDMA from rescuing the cannabinoid-induced memory impairment. The authors suggest this interaction may help explain why some people combine cannabis and ecstasy.
Key Numbers
ACPA at doses of 0.5-4 ng/rat impaired memory retrieval. MDMA at 0.5-1 ug/rat dose-dependently impaired memory alone but reversed ACPA-induced impairment at higher doses. D-AP5 at 1-2 ug/rat blocked MDMA's reversal effect.
How They Did This
Adult male Wistar rats received direct microinjections into the CA1 region of the hippocampus through surgically implanted cannulas. Memory was tested using a step-through passive avoidance task. The NMDA receptor antagonist D-AP5 was used to test the role of glutamate signaling in the interaction.
Why This Research Matters
This study provides insight into the brain mechanisms underlying polydrug use involving cannabis and MDMA. Understanding how these substances interact at the neural level could inform both harm reduction strategies and the development of treatments for cognitive effects of substance use.
The Bigger Picture
Polydrug use involving cannabis and MDMA is common among young adults. Understanding the neurochemical interactions may explain user behavior and help develop interventions. The NMDA receptor finding also adds to our understanding of how cannabinoids affect memory through the glutamate system.
What This Study Doesn't Tell Us
Direct brain injection does not reflect how people actually use these drugs. The synthetic cannabinoid ACPA may have different effects than THC. Rat memory tasks have limited applicability to human cognitive experiences. Doses and routes of administration are not clinically relevant.
Questions This Raises
- ?Does this interaction occur with THC rather than synthetic cannabinoids?
- ?Would systemically administered drugs show the same pattern?
- ?Does this finding have any relevance to the common recreational combination of cannabis and MDMA?
Trust & Context
- Key Stat:
- MDMA reversed cannabinoid-induced memory impairment via NMDA receptors
- Evidence Grade:
- Controlled animal study with clear mechanistic findings, but uses direct brain injection and synthetic cannabinoids with limited clinical relevance.
- Study Age:
- Published in 2016. Research on cannabinoid-MDMA interactions remains an active area of preclinical investigation.
- Original Title:
- Dorsal hippocampal NMDA receptors mediate the interactive effects of arachidonylcyclopropylamide and MDMA/ecstasy on memory retrieval in rats.
- Published In:
- Progress in neuro-psychopharmacology & biological psychiatry, 66, 41-47 (2016)
- Database ID:
- RTHC-01163
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Do cannabis and MDMA interact in the brain?
Yes. In this rat study, MDMA reversed the memory impairment caused by a cannabinoid in the hippocampus, and this interaction depended on NMDA glutamate receptors.
Does this mean combining cannabis and MDMA is safe?
No. This was a highly controlled animal study using direct brain injections of specific compounds. It reveals a neural mechanism but cannot be translated into safety conclusions about recreational polydrug use.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-01163APA
Ghaderi, Marzieh; Rezayof, Ameneh; Vousooghi, Nasim; Zarrindast, Mohammad-Reza. (2016). Dorsal hippocampal NMDA receptors mediate the interactive effects of arachidonylcyclopropylamide and MDMA/ecstasy on memory retrieval in rats.. Progress in neuro-psychopharmacology & biological psychiatry, 66, 41-47. https://doi.org/10.1016/j.pnpbp.2015.11.008
MLA
Ghaderi, Marzieh, et al. "Dorsal hippocampal NMDA receptors mediate the interactive effects of arachidonylcyclopropylamide and MDMA/ecstasy on memory retrieval in rats.." Progress in neuro-psychopharmacology & biological psychiatry, 2016. https://doi.org/10.1016/j.pnpbp.2015.11.008
RethinkTHC
RethinkTHC Research Database. "Dorsal hippocampal NMDA receptors mediate the interactive ef..." RTHC-01163. Retrieved from https://rethinkthc.com/research/ghaderi-2016-dorsal-hippocampal-nmda-receptors
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.